Kaneka Europe Holding Company (Public limited company)
Kaneka Europe Holding Company is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0640.747.653. It was founded on 08-10-2015. Its registered office is in Zaventem. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 207 312 197 and a profit of € 16 864 469. These accounts report 4.9 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 15-10-2026.
Company information
Key figures of Kaneka Europe Holding Company
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 16 864 469+10 % | € 15 279 011-9 % | € 16 733 400+35 % | € 12 401 814 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 207 312 1970 % | € 206 477 5230 % | € 205 675 0220 % | € 204 838 352 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 433 750 866+17 % | € 372 035 727+8 % | € 343 258 541-1 % | € 346 872 496 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | - | - | - |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 4.9+14 % | 4.3+7 % | 4-20 % | 5 |
Financial estimate
- 3 Subsidiaries
- 1 Board links
Similar companies
Other companies in the same activity in Zaventem.
| Company | Town |
|---|---|
| N. TAVITIAN-CONSULTING | 1932 Zaventem |
| ENDOMIXITY | 1932 Zaventem |
| Swedish Orphan Biovitrum (Belgium) | 1932 Zaventem |
| UNIBIOSCIENCE | 1932 Zaventem |
| NEXORA Technologies | 1932 Zaventem |
| BUILDWISE | 1932 Zaventem |
Frequently asked questions
Is Kaneka Europe Holding Company still active? Yes. The Crossroads Bank for Enterprises lists Kaneka Europe Holding Company as active.
What is the VAT number of Kaneka Europe Holding Company? The VAT number of Kaneka Europe Holding Company is BE 0640.747.653.
When was Kaneka Europe Holding Company founded? Kaneka Europe Holding Company was founded on 08-10-2015.
What is the address of Kaneka Europe Holding Company? The current registered office of Kaneka Europe Holding Company is Lenneke Marelaan 4, 1932 Zaventem.
When did Kaneka Europe Holding Company last file annual accounts? The latest annual accounts of Kaneka Europe Holding Company were filed on 13-10-2026.
Does Kaneka Europe Holding Company file its annual accounts on time? Yes. Kaneka Europe Holding Company filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Kaneka Europe Holding Company have? Kaneka Europe Holding Company employs 4.9 full-time equivalents according to its most recent annual accounts.
Is Kaneka Europe Holding Company financially healthy? Addrly gives Kaneka Europe Holding Company a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Kaneka Europe Holding Company profitable? The annual accounts of Kaneka Europe Holding Company for 2025 show a profit of € 16 864 469.
What is the equity of Kaneka Europe Holding Company? The equity of Kaneka Europe Holding Company was € 207 312 197 at the close of the 2025 financial year.
Who are the directors of Kaneka Europe Holding Company? The annual accounts of Kaneka Europe Holding Company record 8 mandates. The names, roles and dates are visible with a free account.
Can Kaneka Europe Holding Company receive Peppol e-invoices? Yes. Kaneka Europe Holding Company is registered on the Peppol network and can receive structured electronic invoices.
What does Kaneka Europe Holding Company do? The main activity of Kaneka Europe Holding Company is: Scientific research and development.